Glycyx Mor, Inc.

Overview

Glycyx is at the forefront of cancer treatment by addressing the overlooked issue of opioids reducing immunotherapy effectiveness. As a biotech firm entering Phase 2, we are pioneering a novel therapy to ensure pain management doesn

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. Pharmaceutical Preparation Manufacturing325412